SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-007490
Filing Date
2024-01-12
Accepted
2024-01-12 16:01:27
Documents
2
Group Members
BETTA PHARMACEUTICALS CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G d636659dsc13g.htm SC 13G 56933
2 EX-99.1 d636659dex991.htm EX-99.1 2865
  Complete submission text file 0001193125-24-007490.txt   61436
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Subject) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91763 | Film No.: 24532040
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 355 XINGZHONG ROAD YUHANG, HANGZHOU F4 311100
Business Address 355 XINGZHONG ROAD YUHANG, HANGZHOU F4 311100 86-571-86130357
Betta Investment (Hong Kong) Ltd. (Filed by) CIK: 0001990727 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13G